Evidence map›Paper›PMID 31619441›Full record

Trial reportCancer prevention research (Philadelphia, Pa.)2020

Effects of Electronic Cigarette Constituents on the Human Lung: A Pilot Clinical Trial.

Min-Ae Song, Sarah A Reisinger, Jo L Freudenheim, Theodore M Brasky, Ewy A Mathé, Joseph P McElroy, Quentin A Nickerson, Daniel Y Weng, Mark D Wewers, Peter G Shields

Open access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Cancer prevention research (Philadelphia, Pa.), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers, 9 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed, 9 pooled it
6.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 9 syntheses or guidelines pooled it, 90 citations in OpenAlex.

  1. Electronic cigarettes for smoking cessation.The Cochrane database of systematic reviews · 2025
    Pooled it
  2. Pooled it
  3. Electronic cigarettes for smoking cessation.The Cochrane database of systematic reviews · 2024
    Pooled it
  4. Electronic cigarettes for smoking cessation.The Cochrane database of systematic reviews · 2022
    Pooled it
  5. Pooled it
  6. Electronic cigarettes for smoking cessation.The Cochrane database of systematic reviews · 2021
    Pooled it
  7. Electronic cigarettes for smoking cessation.The Cochrane database of systematic reviews · 2021
    Pooled it
  8. Lung Damage Caused by Heated Tobacco Products and Electronic Nicotine Delivery Systems: A Systematic Review.International journal of environmental research and public health · 2021
    Pooled it
  9. Electronic cigarettes for smoking cessation.The Cochrane database of systematic reviews · 2020
    Pooled it
  10. Trial
  11. Article
  12. Article
  13. The respiratory epithelium in the era of vaping: insights fromEuropean respiratory review : an official journal of the European Respiratory Society · 2025
    Review
  14. Article
  15. Article
  16. The e-cigarette assessment for youth-Revised (EAsY-R): Preliminary results of a pilot study of measure refinement via cognitive interviewing.Journal of research on adolescence : the official journal of the Society for Research on Adolescence · 2024
    Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Min-Ae SongComprehensive Cancer Center, The Ohio State University and James Cancer Hospital, Columbus, Ohio.
Sarah A ReisingerComprehensive Cancer Center, The Ohio State University and James Cancer Hospital, Columbus, Ohio.
Jo L FreudenheimDepartment of Epidemiology and Environmental Health, School of Public Health and Health Professions, University at Buffalo, Buffalo, New York.ORCID 0000-0002-9301-0499
Theodore M BraskyComprehensive Cancer Center, The Ohio State University and James Cancer Hospital, Columbus, Ohio.
Ewy A MathéComprehensive Cancer Center, The Ohio State University and James Cancer Hospital, Columbus, Ohio.
Joseph P McElroyDepartment of Biomedical Informatics, Center for Biostatistics, The Ohio State University, Columbus, Ohio.
Quentin A NickersonComprehensive Cancer Center, The Ohio State University and James Cancer Hospital, Columbus, Ohio.
Daniel Y WengComprehensive Cancer Center, The Ohio State University and James Cancer Hospital, Columbus, Ohio.
Mark D WewersDepartment of Internal Medicine, Pulmonary and Critical Care Medicine, The Ohio State University, Columbus, Ohio.ORCID 0000-0002-7079-5633
Peter G ShieldsComprehensive Cancer Center, The Ohio State University and James Cancer Hospital, Columbus, Ohio. Peter.Shields@osumc.edu.
The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute · USThe Ohio State University · USUniversity at Buffalo, State University of New York · US

Funding

Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI Daniel G. Stover · 1985 to 2026
$132.3M
The Ohio State University Center for clinical and Translational ScienceUL1TR001070 · NCATS · OHIO STATE UNIVERSITY · PI JACKSON, REBECCA D · 2013 to 2017
$22.6M
Project 4: Comprehension of Health Risks in More and Less Arousing Affe p240-275P50CA180908 · NCI · OHIO STATE UNIVERSITY · PI SHIELDS, PETER G., WEWERS, MARY ELLEN · 2013 to 2017
$18.9M
Mitochondrial Genetic Alterations: A clinical trial of a standardized research e-cigaretteR21HL147401 · NHLBI · OHIO STATE UNIVERSITY · PI SONG, MIN-AE · 2019 to 2020
$429k
NCATS NIH HHS UL1 TR001070NCI NIH HHS P30 CA016058NCI NIH HHS P50 CA180908NHLBI NIH HHS R21 HL147401
6 · The paper itself

Abstract

Electronic cigarette (e-cig) use is continuing to increase, particularly among youth never-smokers, and is used by some smokers to quit. The acute and chronic toxicity of e-cig use is unclear generally in the context of increasing reports of inflammatory-type pneumonia in some e-cig users. To assess lung effects of e-cigs without nicotine or flavors, we conducted a pilot study with serial bronchoscopies over 4 weeks in 30 never-smokers, randomized either to a 4-week intervention with the use of e-cigs containing only 50% propylene glycol (PG) and 50% vegetable glycerine or to a no-use control group. Compliance to the e-cig intervention was assessed by participants sending daily puff counts and by urinary PG. Inflammatory cell counts and cytokines were determined in bronchoalveolar lavage (BAL) fluids. Genome-wide expression, miRNA, and mRNA were determined from bronchial epithelial cells. There were no significant differences in changes of BAL inflammatory cell counts or cytokines between baseline and follow-up, comparing the control and e-cig groups. However, in the intervention but not the control group, change in urinary PG as a marker of e-cig use and inhalation was significantly correlated with change in cell counts (cell concentrations, macrophages, and lymphocytes) and cytokines (IL8, IL13, and TNFα), although the absolute magnitude of changes was small. There were no significant changes in mRNA or miRNA gene expression. Although limited by study size and duration, this is the first experimental demonstration of an impact of e-cig use on inflammation in the human lung among never-smokers.

Indexed as

Electronic Nicotine Delivery SystemsAdministration, InhalationAdultBiomarkersBronchoalveolar Lavage FluidBronchoscopyCross-Sectional StudiesCytokinesEx-SmokersFemaleGene Expression ProfilingGlycerolHumansLungMaleNon-SmokersBiomarkersCytokinesGlycerolPropylene Glycol

Identifiers

PMID31619441
PMCPMC7007320
OpenAlexW2980833448

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.